A Safe, Effective, and Easy to Use Warfarin Initiation Dosing Nomogram for Post-Joint Arthroplasty Patients

Journal of Arthroplasty

Volumn 25, Issue 1, 2010, Pages 121-127

  Pendleton, Robert C ^a   Wheeler, Michelle ^b   Wanner, Nathan ^a   Strong, Michael B ^a   Vinik, Russell ^a   Peters, Christopher L ^c  

^a University Healthcare Thrombosis Service   (United States)

^b UNIVERSITY OF UTAH   (United States)

^c UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

anticoagulation; hemorrhagic complications; joint arthroplasty; nomogram; venous thromboembolism; warfarin

Indexed keywords

WARFARIN;

ADULT; AGED; ARTICLE; BLEEDING; CEREBROVASCULAR ACCIDENT; CLINICAL EVALUATION; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; DRUG EFFICACY; DRUG FATALITY; DRUG SAFETY; EPISTAXIS; FEMALE; HEMATOMA; HIP ARTHROPLASTY; HUMAN; INTERNATIONAL NORMALIZED RATIO; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; NOMOGRAM; VENOUS THROMBOEMBOLISM;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTICOAGULANTS; ARTHROPLASTY, REPLACEMENT, HIP; ARTHROPLASTY, REPLACEMENT, KNEE; FEMALE; HUMANS; INTERNATIONAL NORMALIZED RATIO; MALE; MIDDLE AGED; NOMOGRAMS; VENOUS THROMBOEMBOLISM; WARFARIN; YOUNG ADULT;

EID: 73149085508     PISSN: 08835403     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.arth.2008.09.015     Document Type: Article

References (16)

1. Heit J.A., Silverstein M.D., Mohr D.N., et al. Risk factors for deep vein thrombosis and pulmonary embolism: a population-based case-control study. Arch Intern Med 160 (2000) 809
2. Geerts W.H., Bergqvist D., Pineo G.F., et al. Prevention of venous thromboembolism: American College of Chest Physicians Evidence-based practice guidelines (8th ed.). Chest 133 6 Suppl (2008) 381S
3. Lieberman J.R., and Hsu W.K. Prevention of venous thromboembolic disease after total hip and knee arthroplasty. J Bone Joint Surg Am 87 (2005) 2097
4. Geerts W.H., Heit J.A., Clagett G.P., et al. Prevention of venous thromboembolism. Chest 119 1 Suppl (2001) 132S
5. American Academy of Orthopaedic Surgeons clinical guideline on prevention of symptomatic pulmonary embolism in patients undergoing total hip or knee arthroplasty. (www.aaos.org/research/guidelines/PE_guideline.pdf) accessed April 24, 2008.
6. Anderson Jr. F.A., Hirsh J., White K., et al. Temporal trends in prevention of venous thromboembolism following primary total hip or knee arthroplasty 1996-2001: findings from the Hip and Knee Registry. Chest 124 6 Suppl (2003) 349S
7. Ansell J., Hirsh J., Poller L., et al. The pharmacology and management of the vitamin K antagonists: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 126 3 Suppl (2004) 204S
8. Anderson D.R., Wilson S.J., Blundell J., et al. Comparison of a nomogram and physician-adjusted dosage of warfarin for prophylaxis against deep-vein thrombosis after arthroplasty. J Bone Joint Surg Am 84-A (2002) 1992
9. Asnis P.D., Gardner M.J., Ranawat A., et al. The effectiveness of warfarin dosing from a nomogram compared with house staff dosing. J Arthroplasty 22 (2007) 213
10. Gedge J., Orme S., Hampton K., et al. A comparison of a low-dose warfarin induction regimen with the modified Fennerty regimen in elderly inpatients. Age Ageing 29 (2000) 31
11. Kovacs M.J., Rodger M., Anderson D.R., et al. Comparison of 10-mg and 5-mg warfarin initiation nomograms together with low-molecular-weight heparin for outpatient treatment of acute venous thromboembolism. A randomized, double-blind, controlled trial. Ann Intern Med 138 (2003) 714
12. Siguret V., Gouin I., Debray M., et al. Initiation of warfarin therapy in elderly medical inpatients: a safe and accurate regimen. Am J Med 118 (2005) 137
13. Harrison L., Johnson M., Mossicotte M.P., et al. Comparison of 5-mg and 10-mg loading doses in initiation of warfarin therapy. Ann Intern Med 126 (1997) 133
14. Mismetti P., Laporte S., Zufferey P., et al. Prevention of venous thromboembolism in orthopedic surgery with vitamin K antagonists: a meta-analysis. J Thromb Haemost 2 (2004) 1058
15. Yin T., and Miyata T. Warfarin dose and the pharmacogenomics of CYP2C9 and VKORC1-rationale and perspectives. Thromb Res 120 (2007) 1
16. Lenzini P.A., Grice G.R., Milligan P.E., et al. Optimal initial dose adjustment of warfarin in orthopedic patients. Ann Pharmacother 41 (2007) 1798